106 related articles for article (PubMed ID: 26493311)
21. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
[TBL] [Abstract][Full Text] [Related]
22. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
[TBL] [Abstract][Full Text] [Related]
23. Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy.
Chatterjee A; Mir SA; Dutta D; Mitra A; Pathak K; Sarkar S
J Cell Physiol; 2011 Oct; 226(10):2543-54. PubMed ID: 21792911
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
26. Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Zou XJ; Yang L; Yao SL
Exp Biol Med (Maywood); 2008 Feb; 233(2):200-8. PubMed ID: 18222975
[TBL] [Abstract][Full Text] [Related]
27. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
29. Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways.
Tang K; Zhong B; Luo Q; Liu Q; Chen X; Cao D; Li X; Yang S
Eur J Pharmacol; 2022 Jul; 927():175022. PubMed ID: 35569549
[TBL] [Abstract][Full Text] [Related]
30. 6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro.
Alammari AH; Gerges SH; Isse FA; El-Kadi AOS
Drug Metab Dispos; 2023 Jul; 51(7):833-843. PubMed ID: 37185150
[TBL] [Abstract][Full Text] [Related]
31. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation.
Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Falck JR; Malik KU
Prostaglandins Other Lipid Mediat; 2013; 102-103():31-41. PubMed ID: 23454652
[TBL] [Abstract][Full Text] [Related]
32. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
Maayah ZH; Althurwi HN; Abdelhamid G; Lesyk G; Jurasz P; El-Kadi AO
Pharmacol Res; 2016 Mar; 105():28-43. PubMed ID: 26772815
[TBL] [Abstract][Full Text] [Related]
33. Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo.
Si L; Xu J; Yi C; Xu X; Wang F; Gu W; Zhang Y; Wang X
Int J Mol Med; 2014 Aug; 34(2):499-506. PubMed ID: 24827470
[TBL] [Abstract][Full Text] [Related]
34. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
[TBL] [Abstract][Full Text] [Related]
35. The TIR/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-κB dependent downregulation of miRNA-143.
Song J; Xie Q; Wang L; Lu Y; Liu P; Yang P; Chen R; Shao C; Qiao C; Wang Z; Yan J
Sci Rep; 2019 Apr; 9(1):6354. PubMed ID: 31015570
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress.
Korashy HM; Attafi IM; Ansari MA; Assiri MA; Belali OM; Ahmad SF; Al-Alallah IA; Anazi FE; Alhaider AA
Toxicol Lett; 2016 Jun; 252():50-61. PubMed ID: 27084042
[TBL] [Abstract][Full Text] [Related]
37. 2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy.
Maayah ZH; Levasseur J; Siva Piragasam R; Abdelhamid G; Dyck JRB; Fahlman RP; Siraki AG; El-Kadi AOS
Sci Rep; 2018 Feb; 8(1):2780. PubMed ID: 29426916
[TBL] [Abstract][Full Text] [Related]
38. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
39. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
40. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway.
Yang L; Zou X; Liang Q; Chen H; Feng J; Yan L; Wang Z; Zhou D; Li S; Yao S; Zheng Z
Exp Mol Med; 2007 Feb; 39(1):65-73. PubMed ID: 17334230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
